Home » Posts tagged 'oncimmune'
Tag Archives: oncimmune
Ian Pollard – More World Beating Technology From The UK
Oncimmune ONC bears witness to the world leading position which it is carving out for itself in medical technology. with the half year to the 30th November seeing excellent progress being made with its cancer detection technology which will detect cancers up to four years earlier than other methods and will do so by means of a simple blood test
The half year produced revenue of only £0.1m from early sales of its lung test kit but far more importantly for the future it took serious strides in establishing its technology and products in world markets.An exclusive distribution agreement and product development agreement was concluded in China, which included a minimum £10m. equity investment in the company plus a minimum £15.7m in royalties. Further agreements have been reached in twelve countries with minimum sales commitments amounting to £25.6m and in the US a preliminary distribution partnership has been entered into with a major US company. In the UK over 12,000 patients have been recruited for a lung cancer screening trial.
Liver test kits have commenced commercial sales and early lung cancer kits have received minimum payment guarantees of £7.9m over the next five years in the Asia Pacific region, excluding China, plus approximately £2m in Europe
TUI AG TUI has made a good start to the year with first quarter turnover rising by 8.1% and the net loss down from 81.6m to 58.7m. On an underlying like for like basis EBIT was up by 35.1% and net debt was halved. Expectations are that underlying EBITA growth for 2018 will be at least 10%.
RWS Holdings RWS The financial year to the end of September saw the fourteenth successive year of growth in sales, profits and dividends and RWS is confident of further substantial progress in 2018, when, despite currency headwinds in the US it aims to consolidate its global leading position in its chosen sectors. The integration of Monrovia which it acquired on the 3rd November will continue and the current financial year has started well.
Beachfront villas & houses for sale in Greece; http://www.hiddengreece.net
Ian Pollard – Next #NXT succumbs to High St woes
NEXT NXT colder weather and a big rise in online sales helped Next to beat expectations for full price sales in the 54 days between 1st November and the 24th December, with a rise of 1.5% as against an expected fall of -0.3%. Within that figure however, retail sales were a disaster with a fall of 6.1% compared to a rise of 13.6% in online sales. Trading for the year as a whole, the 52 weeks to January 2018,was nothing less than disastrous with group profit before tax down by 8.3% slightly better than the expected 9.3%. For 2018 the decline is expected to continue albeit at a reduced rate as subdued consumer demand and a continued decline in real incomes continue to wreak havoc on the high street.
Plus 500 PLUS expects revenue and profits for the year to the 31st December will be ahead of expectations after record revenues were achieved in the fourth quarter, as well as 246,000 new customers.
Oncimmune ONC listed on AIM in May 2016 with its main aim being to enter the Chinese market with its early cancer detection test. The Chinese are heavy smokers and lung cancer deaths alone, now exceed 700,000 each year, due in part to late detection. Oncimmune’s test can detect cancer up to 4 years earlier than conventional methods and the company announced over Christmas that it has reached a distributorship deal with Genostics, a Hong Kong company which has acquired over 6 million shares in Oncimmune at a price of £1.56. Oncimmunes shares jumped to £1.29 yesterday, a rise of 23%
December traffic statistics saw Wizz Air increase capacity by 19.4% and passengers by 19.8%, with load factor up slightly at 87.5%. Ryanair December traffic rose by 3% whilst load factor was up by 1% to 95%
Find beachfront villas & houses for sale in Greece; http://www.hiddengreece.net